Metformin and survival: Is there benefit in a cohort limited to diabetic women with endometrial, breast, or ovarian cancer? - Lemon LS; Orr B; Modugno F; Buckanovich RJ; Coffman L; Edwards RP; Taylor S (Gynecologic oncology, 2022)